Laser medical device maker Lumenis (Nasdaq:LUME) said on Tuesday it received U.S. Food and Drug Administration clearance to market lasers for tooth whitening and other oral procedures.
Lumenis said it will market its Opus 5 and Opus 10 compact, portable diode lasers used for tooth whitening, root canal disinfection, periodontal procedures, gingivoplasty and microsurgery.
The company said it signed a distribution agreement with Minnesota-based Patterson Dental Supply (Nasdaq:PDCO) to market the systems in the United States.
"Tooth whitening is a rapidly growing application with a market potential of over $1 billion," said Lumenis chief executive officer Yacha Sutton.
He noted Lumenis, formed by the merger of ESC Medical Systems and Coherent Medical Group, "should be well positioned to capture a substantial portion of the market."